| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 0.07 | 0.12 | 0.28 | 0.18 | 0.31 |
| Other Income | 2.04 | 7.37 | 0.66 | 0.17 | 0.02 |
| Stock Adjustments | 0 | -0.01 | 0 | 0 | 0 |
| Total Income | 2.11 | 7.48 | 0.94 | 0.35 | 0.33 |
| EXPENDITURE : | |||||
| Raw Materials | 0.03 | 0.03 | 0 | 0 | 0.01 |
| Excise Duty | 0 | 0 | 0 | 0 | 0 |
| Power and Fuel Cost | 0.06 | 0.06 | 0.12 | 0.1 | 0.16 |
| Other Manufacturing Expenses | 0.04 | 0.01 | 0.02 | 0.06 | 0.11 |
| Employee Cost | 0.25 | 0.33 | 0.55 | 0.68 | 1.04 |
| Selling and Administration Expenses | 0.35 | 0.25 | 0.2 | 0.47 | 0.59 |
| Miscellaneous Expenses | 0.02 | 1.53 | 1.95 | 0 | 0.01 |
| Less: Preoperative Expenditure Capitalised | 0 | 0 | 0 | 0 | 0 |
| Profit before Interest, Depreciation and Tax | 1.36 | 5.27 | -1.9 | -0.97 | -1.59 |
| Interest and Financial Charges | 0.26 | 1.03 | 0.43 | 0.07 | 0.36 |
| Profit before Depreciation and Tax | 1.1 | 4.24 | -2.33 | -1.04 | -1.95 |
| Depreciation | 9.89 | 9.89 | 17.53 | 20.5 | 17.18 |
| Minority Interest before PAT | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -8.79 | -5.65 | -19.86 | -21.54 | -19.14 |
| Tax | 0 | 0.79 | 0 | 0 | 0 |
| Profit After Tax | -8.79 | -6.44 | -19.86 | -21.54 | -19.14 |
| Minority Interest after PAT | 0 | 0 | 0 | 0 | 0 |
| Profit/Loss of Associate Company | 0 | 0 | 0 | 0 | 0 |
| Profit after Minority Interest and P/L of Assoc. Co. | -8.79 | -6.44 | -19.86 | -21.54 | -19.14 |
| Adjustment below Net Profit | 0 | 0 | -2.21 | -1.95 | 0 |
| P and L Balance brought forward | -170.62 | -164.18 | -142.12 | -138.62 | -119.49 |
| Appropriations | 0 | 0 | 0 | 0 | 0 |
| P and L Bal. carried down | -179.42 | -170.62 | -164.18 | -162.11 | -138.62 |
| Equity Dividend | 0 | 0 | 0 | 0 | 0 |
| Preference Dividend | 0 | 0 | 0 | 0 | 0 |
| Corporate Dividend Tax | 0 | 0 | 0 | 0 | 0 |
| Equity Dividend (%) | 0 | 0 | 0 | 0 | 0 |
| Earning Per Share (Rs.) | 0 | 0 | 0 | 0 | 0 |
| Book Value | 5.76 | 6.92 | 7.77 | 23.02 | 25.26 |
| Extraordinary Items | 1.77 | 2.9 | 0 | 0 | -0.01 |
| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Share Capital | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 |
| Reserves and Surplus | -32.13 | -23.34 | -16.9 | 98.67 | 115.62 |
| Total Shareholders Funds | 43.64 | 52.43 | 58.87 | 174.44 | 191.39 |
| Secured Loans | 3.95 | 3.69 | 5.19 | 6.34 | 6.27 |
| Unsecured Loans | 121.46 | 122.6 | 133.1 | 129.82 | 129.04 |
| Total Debt | 125.41 | 126.29 | 138.29 | 136.16 | 135.31 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 169.05 | 178.72 | 197.16 | 310.6 | 326.7 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 107.58 | 107.55 | 107.86 | 208.37 | 208.37 |
| Less: Accum. Depreciation | 66.48 | 56.58 | 46.69 | 67.42 | 44.97 |
| Net Block | 41.1 | 50.97 | 61.17 | 140.95 | 163.4 |
| Capital Work in Progress | 1.87 | 1.87 | 2.04 | 0.29 | 0.29 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Current Assets, Loans and Advances | |||||
| Inventories | 0.03 | 0.04 | 0.07 | 0.07 | 0.07 |
| Sundry Debtors | 0.01 | 0.01 | 0.01 | 1.64 | 16.4 |
| Cash and Bank Balance | 0.1 | 0.1 | 0.05 | 0.03 | 0.03 |
| Loans and Advances | 133.44 | 133.56 | 134.74 | 170.02 | 163.59 |
| Less: Current Liab. and Prov. | |||||
| Current Liabilities | 0.52 | 0.83 | 0.91 | 2.38 | 17.08 |
| Provisions | 6.99 | 6.99 | 0 | 0 | 0 |
| Net Current Assets | 126.07 | 125.89 | 133.96 | 169.38 | 163.01 |
| Miscellaneous Expenses not w/o | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 169.04 | 178.73 | 197.17 | 310.62 | 326.7 |
| Contingent Liabilities | 0 | 0 | 0.99 | 0 | 0.99 |
If I had made LUMPSUM investment of ₹ 1,00,000
in TRANSGENE BIOTEK LTD.
Months ago
My investment would be worth
₹ 1,41,900
with a Gain of
41.90 %
